1038726-89-4

Basic information

• Product Name: (2-chloro-6-methoxyphenyl)methanol
• Synonyms: (2-chloro-6-methoxyphenyl)methanol;2-chloro-6-methoxybenzenemethanol
• CAS NO: 1038726-89-4
• Molecular Formula: C₈H₉ClO₂
• Molecular Weight: 172.60886
• Mol File: 1038726-89-4.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 268.2±25.0 °C(Predicted)
• Appearance: /
• Density: 1.239±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 14.01±0.10(Predicted)
• CAS DataBase Reference: (2-chloro-6-methoxyphenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2-chloro-6-methoxyphenyl)methanol(1038726-89-4)
• EPA Substance Registry System: (2-chloro-6-methoxyphenyl)methanol(1038726-89-4)

Safety Data

• Hazardous Substances Data: 1038726-89-4(Hazardous Substances Data)

Usage

General Description

(2-chloro-6-methoxyphenyl)methanol is a chemical compound with the molecular formula C8H9ClO2. It is a white to off-white solid that is commonly used in organic synthesis as a reagent for the preparation of various pharmaceutical and agrochemical products. It is also known for its use in the production of dyes and other chemical intermediates. (2-chloro-6-methoxyphenyl)methanol is derived from phenol and can be synthesized through a series of chemical reactions. It is important to handle and store (2-chloro-6-methoxyphenyl)methanol with care, as it is considered harmful if absorbed through the skin or ingested, and it can cause irritation to the eyes and respiratory system.

Upstream product

• 29866-54-4 2-chloro-6-methoxybenzaldehyde 
• 54166-96-0 methyl 2-amino-6-methoxybenzoate 
• 3260-89-7 2-chloro-6-methoxybenzoic acid 
• 936479-46-8 methyl 6-chloro-2-methoxybenzoate 

Downstream Products

• 29866-54-4 2-chloro-6-methoxybenzaldehyde 
• 83781-95-7 2-(2-chloro-6-methoxyphenyl)acetonitrile 
• 18362-30-6 2-chloro-6-hydroxybenzaldehyde 
• 1154740-80-3 6-chloro-2H-chromene-3(4H)-one 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION

The present disclosure relates generally to compounds and pharmaceutical compositions for the selective inhibition of histone lysine demethylase5 (KDM5), particularly KDM5B, and methods of their use in treating conditions and diseases associated with KDM5 activity.

N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS

The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.